SCHEMBL1903027

SCHEMBL1903027

C1=CC2=CCSC2=CC=N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3319778 0.68 — —
SCHEMBL207437 0.68 — —
SCHEMBL10878614 0.68 — —
SCHEMBL31563804 0.65 — —
Hydrochloric Acid SCHEMBL31564118 0.62 — —
SCHEMBL3630049 0.60 ALDH1A1 (0.30) —
SCHEMBL6234127 0.56 — —
SCHEMBL6993877 0.53 — —
SCHEMBL511838 0.52 — —
SCHEMBL31511771 0.51 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1258533-C Antihistaminic spiro compounds JANSSEN PHARMACEUTICA NV (BE) 2006-06-07 — — CN claimed
EP-4380941-A1 TRICYCLIC FUSED PYRIMIDINE COMPOUNDS FOR USE AS HER2 INHIBITORS Bristol-Myers Squibb Company (US) 2024-06-12 — — EP disclosed
WO-2023015240-A1 TRICYCLIC FUSED PYRIMIDINE COMPOUNDS FOR USE AS HER2 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2023-02-09 — — WO disclosed
CN-106852144-B 5,6- dihydro -4H- benzo [b] thieno-[2,3-d] azepine * derivative 普尔莫赛德有限公司 2019-08-30 — — CN disclosed
CN-106852144-B 5,6- dihydro -4H- benzo [b] thieno-[2,3-d] azepine * derivative 普尔莫赛德有限公司 2019-08-30 — — CN disclosed
CN-106852144-B 5,6- dihydro -4H- benzo [b] thieno-[2,3-d] azepine * derivative 普尔莫赛德有限公司 2019-08-30 — — CN disclosed
EP-3204388-A1 NOVEL 5,6-DIHYDRO-4H-BENZO[B]THIENO-[2,3-D]AZEPINE DERIVATIVES Pulmocide Limited (GB) 2017-08-16 — — EP disclosed
CN-106852144-A 5,6 new dihydro 4H benzo [b] thieno [2,3 d] azepine * derivatives 普尔莫赛德有限公司 2017-06-13 — — CN disclosed
WO-2016055792-A1 NOVEL 5,6-DIHYDRO-4H-BENZO[B]THIENO-[2,3-D]AZEPINE DERIVATIVES PULMOCIDE LIMITED (GB) 2016-04-14 — — WO disclosed
CN-103214414-B The diamine derivative of opticity and manufacture method thereof SANKYO CO. (JP) 2016-02-17 — — CN disclosed
CN-1745071-A Novel ethylenediamine derivative DAIICHI SEIYAKU CO (JP) 2006-03-08 — — CN disclosed
EP-1303521-B1 TETRAHYDRO-HETEROCYCLOAZEPINYL PYRIMIDINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2005-02-02 — — EP disclosed
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 — — EP disclosed
US-20020045635-A1 Novel mGluR antagonists and a method for their synthesis HOFFMANN-LA ROCHE, INC. 2002-04-18 — — US disclosed
US-6369222-B1 NITRO- AND CYANO-1,2,4,5-TETRAHYDRO-HETEROCYCLOAZEPINYL PYRIMIDINE DERIVATIVES; BRAIN, EYE, MUSCULAR, PSYCHOLOGICAL AND NERVOUS SYSTEM DISORDERS HOFFMANN-LA ROCHE INC. 2002-04-09 — — US disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 — — US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 — — EP disclosed
EP-0324610-B1 Thieno[2,3-d]azepine derivatives, process for their preparation and pharmaceutical compositions containing them LILLY INDUSTRIES LTD (GB) 1994-04-13 — — EP disclosed
EP-0324610-A3 Thieno[2,3-d]azepine derivatives, process for their preparation and pharmaceutical compositions containing them LILLY INDUSTRIES LIMITED (GB) 1991-03-13 — — EP disclosed
EP-0324610-A2 Thieno[2,3-d]azepine derivatives, process for their preparation and pharmaceutical compositions containing them LILLY INDUSTRIES LIMITED (GB) 1989-07-19 — — EP disclosed
Send feedback